Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease

Induced pluripotent stem cell (iPSC)-derived dopaminergic (DA) neurons are an expected source for cell-based therapies for Parkinson’s disease (PD). The regulatory criteria for the clinical application of these therapies, however, have not been established. Here we show the results of our pre-clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Doi, Daisuke, Magotani, Hiroaki, Kikuchi, Tetsuhiro, Ikeda, Megumi, Hiramatsu, Satoe, Yoshida, Kenji, Amano, Naoki, Nomura, Masaki, Umekage, Masafumi, Morizane, Asuka, Takahashi, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338530/
https://www.ncbi.nlm.nih.gov/pubmed/32632153
http://dx.doi.org/10.1038/s41467-020-17165-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338530/
https://www.ncbi.nlm.nih.gov/pubmed/32632153
http://dx.doi.org/10.1038/s41467-020-17165-w

Ejemplares similares